JP2023533932A5 - - Google Patents

Info

Publication number
JP2023533932A5
JP2023533932A5 JP2022581707A JP2022581707A JP2023533932A5 JP 2023533932 A5 JP2023533932 A5 JP 2023533932A5 JP 2022581707 A JP2022581707 A JP 2022581707A JP 2022581707 A JP2022581707 A JP 2022581707A JP 2023533932 A5 JP2023533932 A5 JP 2023533932A5
Authority
JP
Japan
Prior art keywords
compound
formula
stereoisomer
carbonnitrile
fluoropyrrolidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022581707A
Other languages
English (en)
Japanese (ja)
Other versions
JP7628716B2 (ja
JP2023533932A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/068577 external-priority patent/WO2022008477A1/en
Publication of JP2023533932A publication Critical patent/JP2023533932A/ja
Publication of JP2023533932A5 publication Critical patent/JP2023533932A5/ja
Application granted granted Critical
Publication of JP7628716B2 publication Critical patent/JP7628716B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022581707A 2020-07-07 2021-07-06 1-[1-(4-ベンジルオキシ-3,5-ジフルオロ-ベンゾイル)-4-フルオロ-ピロリジン-2-カルボニル]-ピロリジン-2-カルボニトリル Active JP7628716B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20382606.0 2020-07-07
EP20382606 2020-07-07
PCT/EP2021/068577 WO2022008477A1 (en) 2020-07-07 2021-07-06 1-[1-(4-benzyloxy-3,5-difluoro-benzoyl)-4-fluoro-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile

Publications (3)

Publication Number Publication Date
JP2023533932A JP2023533932A (ja) 2023-08-07
JP2023533932A5 true JP2023533932A5 (enExample) 2024-07-01
JP7628716B2 JP7628716B2 (ja) 2025-02-12

Family

ID=71607883

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022581707A Active JP7628716B2 (ja) 2020-07-07 2021-07-06 1-[1-(4-ベンジルオキシ-3,5-ジフルオロ-ベンゾイル)-4-フルオロ-ピロリジン-2-カルボニル]-ピロリジン-2-カルボニトリル

Country Status (19)

Country Link
US (1) US12459891B2 (enExample)
EP (1) EP4178945B1 (enExample)
JP (1) JP7628716B2 (enExample)
KR (1) KR20230035604A (enExample)
CN (1) CN117545738A (enExample)
AU (1) AU2021303440A1 (enExample)
BR (1) BR112023000335A2 (enExample)
CA (1) CA3185064A1 (enExample)
ES (1) ES2997164T3 (enExample)
HR (1) HRP20241527T1 (enExample)
HU (1) HUE068953T2 (enExample)
IL (1) IL299035B1 (enExample)
MA (1) MA60250B1 (enExample)
MX (1) MX2023000261A (enExample)
RS (1) RS66215B1 (enExample)
SM (1) SMT202400460T1 (enExample)
TW (1) TWI893162B (enExample)
WO (1) WO2022008477A1 (enExample)
ZA (1) ZA202213708B (enExample)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159938A (en) 1994-11-21 2000-12-12 Cortech, Inc. Serine protease inhibitors comprising α-keto heterocycles
DE19603510A1 (de) 1996-02-01 1997-08-07 Knoell Hans Forschung Ev Die Verwendung von Terrecyclolsäure A und Terrecyclolsäure A-Derivate als neue Inhibitoren der humanen Prolyl-Oligopeptidase
FI20011466A0 (fi) 2001-07-04 2001-07-04 Orion Corp Prolyylioligopeptidaasia inhiboivaa aktiivisuutta omaavia yhdisteitä, niiden valmistusmenetelmiä ja käyttö
FI20030014A0 (fi) 2003-01-03 2003-01-03 Orion Corp Prolyylioligopeptidaasia inhiboivaa aktiivisuutta omaavia yhdisteitä
FI20031018A0 (fi) 2003-07-04 2003-07-04 Orion Corp Parannus aivovammasta toipumiseen
WO2005027934A1 (ja) 2003-09-24 2005-03-31 Nippon Kayaku Kabushiki Kaisha プロリルオリゴペプチダーゼ阻害剤
US7667044B2 (en) 2003-11-03 2010-02-23 Probiodrug Ag Compounds for the treatment of neurological disorders
ES2302473B1 (es) 2006-12-22 2009-06-12 Universidad De Barcelona Agente terapeutico para el tratamiento del desorden afectivo bipolar en mamiferos.
EP2730571A1 (en) * 2012-11-12 2014-05-14 Universitat De Barcelona 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives

Similar Documents

Publication Publication Date Title
JP5377285B2 (ja) キラルアミドおよびキラルアミンの調製
CN1041827C (zh) 被取代的3-氨基奎宁环化合物的制备方法
RU2009138602A (ru) Новые производные бензазепина
JP2007291124A (ja) α2δ−タンパク質に親和性を有するアミノ酸
JP2022515293A5 (enExample)
JP2006523700A (ja) ピロリジンカルボン酸の調製のための方法及び中間体
RU2003128535A (ru) Гетерополициклическое соединение (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, ассоциированного с активацией метаботропных глютаматных рецепторов (варианты)
JP2006022107A5 (enExample)
CN1882581A (zh) N-[杂芳基(哌啶-2-基)甲基]苯甲酰胺衍生物及其制备方法和它们的治疗应用
JP2018505204A5 (enExample)
JP2019525939A5 (enExample)
EP1841726B1 (en) An asymmetric synthesis of (s)-(+)-3-(aminomethyl)-5-methylhexanoic acid
EP1876168B1 (de) Verfahren zur Herstellung von beta-Amino-alpha-hydroxy-carbonsäureamiden
JP2021534227A5 (enExample)
JP2015536965A5 (enExample)
JP2014518552A5 (enExample)
JP2020507567A5 (enExample)
ME02706B (me) Derivati 1·[1-(benzoil)-pirolidin-2-karbonil] -pirolidin-2-karbonitrila
JP5243539B2 (ja) 1,2−置換3,4−ジオキソ−1−シクロブテン化合物の合成のための方法および中間体
JP2009525324A5 (enExample)
JP2019535715A5 (enExample)
CN1147243A (zh) 由环氧化物制备顺式-1-氨基-2-链烷醇的区域专一性方法
CN1352629A (zh) 外消旋化光活性胺的方法
HRP20241527T1 (hr) 1-[1-(4-benziloksi-3,5-difluorbenzoil)-4-fluorpirolidin-2-karbonil]pirolidin-2-karbonitril
CN1842514A (zh) 环烷基氨基酸化合物及其制备方法和用途